Targeting TROP2 in EGFR-Mutated Advanced NSCLC: Navigating the ADC Revolution After TKI Failure 

Explore the roles of TROP2-directed ADCs in EGFR-mutated advanced NSCLC after TKI failure, with practical guidance on patient selection and toxicity management.